Minimization of chronic plasma viremia in rhesus macaques immunized with synthetic HIV-1 Tat peptides and infected with a chimeric simian/human immunodeficiency virus (SHIV 33 )

By Goldstein G.   Manson K.   Tribbick G.   Smith R.  

Vaccine, Vol. 18, Iss. 25, 2000-06 ,pp. : 2789-2795

Elsevier

Access to resources Recommend Favorite

Simian immunodeficiency virus (SIV)-specific CD8 + cytotoxic T lymphocyte responses of naive and vaccinated cynomolgus macaques infected with SIVmac32H (J5): quantitative analysis by in vitro antigenic stimulation

By Geretti A.-M.   Hulskotte E.G.J.   Dings M.E.M.   van Baalen C.A.   van Amerongen G.   Osterhaus A.D.M.E.  

Vaccine, Vol. 15, Iss. 11, 1997-08 ,pp. : 1269-1275

Elsevier

Access to resources Recommend Favorite

Enhanced simian immunodeficiency virus-specific immune responses in macaques induced by priming with recombinant Semliki Forest virus and boosting with modified vaccinia virus Ankara

By Nilsson C.   Makitalo B.   Berglund P.   Bex F.   Liljestrom P.   Sutter G.   Erfle V.   ten Haaft P.   Heeney J.   Biberfeld G.   Thorstensson R.  

Vaccine, Vol. 19, Iss. 25, 2001-05 ,pp. : 3526-3536

Elsevier

Access to resources Recommend Favorite

The critical role of CD4 + T-cell help in immunity to HIV

By Heeney J.L.  

Vaccine, Vol. 20, Iss. 15, 2002-05 ,pp. : 1961-1963

Elsevier

Access to resources Recommend Favorite

Chimeras between the human immunodeficiency virus (HIV-1) Env and vaccinia virus immunogenic proteins p14 and p39 generate in mice broadly reactive antibodies and specific activation of CD8+ T cell responses to Env

By Collado  

Vaccine, Vol. 18, Iss. 27, 2000-07 ,pp. : 3123-3133

Elsevier

Access to resources Recommend Favorite